{"id":"W2072298846","doi":"10.1097/wco.0000000000000202","title":"Established disease-modifying treatments in relapsing-remitting multiple sclerosis","year":2015,"lang":"en","type":"review","venue":"Current Opinion in Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"U.S. Food and Drug Administration","keywords":"Teriflunomide; Fingolimod; Natalizumab; Glatiramer acetate; Tolerability; Medicine; Multiple sclerosis; Relapsing remitting; Dimethyl fumarate; Disease; Intensive care medicine; Adverse effect; Internal medicine; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001059185,0.0008664989,0.002051944,0.00323935,0.0002613958,0.000995046,0.0009343058,0.0009675394,0.004389797],"category_scores_gemma":[0.002154012,0.0002569738,0.000859595,0.002988404,0.0003747804,0.001093682,0.0006203366,0.001217464,0.001486212],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006083692,"about_ca_system_score_gemma":0.001866492,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001225978,"about_ca_topic_score_gemma":0.002318013,"domain_scores_codex":[0.9994794,0.00009776819,0.0001450766,0.00006007565,0.000188672,0.00002902515],"domain_scores_gemma":[0.9989551,0.000528435,0.0002215906,0.00002114343,0.0002280589,0.00004558282],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009664198,0.00005546523,0.0002298003,0.1109936,0.0003145111,0.0001592599,0.00008423533,0.0001304601,0.0008293836,0.001105608,0.02042371,0.8655773],"study_design_scores_gemma":[0.00007214275,0.0001896001,0.002174539,0.05250569,0.00141726,0.001759365,0.0001560644,0.00006986329,0.0006016909,0.001086358,0.9399325,0.00003497266],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004975679,0.9994887,0.00002509743,0.00008712209,0.00008710913,0.000006114609,0.00001360053,0.000002486722,0.0002399707],"genre_scores_gemma":[0.0002907623,0.9993585,0.00007964121,0.0000832631,0.00007050776,0.000006243964,0.00001755953,4.90923e-7,0.00009312938],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004389797,"threshold_uncertainty_score":0.01468533,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4128435624167878,"score_gpt":0.4578714330300615,"score_spread":0.04502787061327373,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}